▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4 by analyst upside · 2026-06-24
MSS
Maison Solutions Inc.
Consumer Defensive · Market Cap $2M · P/E 0x
ANALYST PRICE TARGET
+4429.0%
implied upside to consensus target
Current Price $0.72
Consensus Target $32.5
Bull Target $32.5
Bear Target $32.5
Analysts Covering 1
ANALYST CONSENSUS — BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $0.65
52-Week High $39.6
YTD Return -76.7%
FUNDAMENTALS
Market Cap $2M
P/E Ratio (TTM) N/A
Forward P/E 1.4x
EPS (TTM) $-5.35
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $119M
Profit Margin -10.1%
52-WEEK RANGE
52-Week Low $0.65
52-Week High $39.6
Current Price $0.72
Bear Target $32.5
Bull Target $32.5
● Now $0.72 ● Target $32.5
TRADING DATA
Avg Volume 400K
YTD Return -76.7%
Analyst Count 1
Consensus Buy
Upside to Target +4429.0%
Last Updated 2026-06-24

ANALYST SUMMARY

Maison Solutions Inc. (MSS) is currently trading at $0.72 with a Wall Street consensus price target of $32.5, implying potential upside of 4429.0% over the next 12 months. 1 analysts currently cover MSS, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $32.5, while the most cautious has a target of $32.5.

MSS operates in the Consumer Defensive sector with a market capitalisation of $2M. The stock is down 76.7% year-to-date and is currently trading near the lower end of its 52-week range of $0.65 – $39.6.

SIMILAR STOCKS

Other Consumer Defensive stocks with comparable size and valuation.

VFF +160.1%
Village Farms International, In
$230M · P/E 8.2x · Buy
FTLF +57.9%
FitLife Brands, Inc.
$104M · P/E 18.5x · Buy
BUDA +49.1%
Buda Juice, Inc.
$118M · P/E 37.6x · Buy
USNA +88.4%
USANA Health Sciences, Inc.
$382M · P/E 41.4x · Hold
DDL +75.3%
Dingdong (Cayman) Limited
$418M · P/E 17.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MSS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Ascendiant Capital — Reiterated
Buy → Buy 2026-04-14 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-12-30 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-09-24 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-09-23 Building track record
Ascendiant Capital ● Initiated
Buy 2025-09-15 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →